{"id":21792,"date":"2026-10-21T18:39:34","date_gmt":"2026-10-21T18:39:34","guid":{"rendered":"https:\/\/veilles-affaires-sociales.fr\/?p=21792"},"modified":"2026-10-21T18:39:34","modified_gmt":"2026-10-21T18:39:34","slug":"presentation-et-enregistrement-webinaire-en-direct-euhpp-sur-les-politiques-relatives-aux-biosimilaires-en-pratique-principaux-resultats-des-visites-detude-augment-19-octobre-2026","status":"publish","type":"post","link":"https:\/\/veilles-affaires-sociales.fr\/?p=21792","title":{"rendered":"Pr\u00e9sentation et enregistrement &#8211; Webinaire en direct EUHPP sur les politiques relatives aux biosimilaires en pratique : principaux r\u00e9sultats des visites d\u2019\u00e9tude AUGMENT (19 octobre 2026)\u00a0(titre traduit en fran\u00e7ais par l&rsquo;IA)"},"content":{"rendered":"<p>Un webinaire consacr\u00e9 aux politiques relatives aux biosimilaires, intitul\u00e9 \u00ab Biosimilar Policies in Practice: Key Findings from the AUGMENT Study Visits \u00bb, a \u00e9t\u00e9 mis en ligne sur la plateforme europ\u00e9enne EU Health Policy Platform. L\u2019enregistrement est accessible jusqu\u2019au 29 octobre 2026 au moyen d\u2019un mot de passe sp\u00e9cifique, et l\u2019ensemble des pr\u00e9sentations utilis\u00e9es lors de la session a \u00e9t\u00e9 regroup\u00e9 dans un seul fichier t\u00e9l\u00e9chargeable sur la plateforme.<\/p>\n<p>Ce webinaire s\u2019inscrit dans le cadre du projet AUGMENT Biosimilars (\u00ab Capacity building to support the uptake of biosimilars in a multistakeholder approach \u00bb), centr\u00e9 sur le renforcement des capacit\u00e9s pour favoriser l\u2019adoption des biosimilaires via une approche impliquant plusieurs parties prenantes. Il pr\u00e9sente les retours d\u2019exp\u00e9rience et principaux enseignements de cinq visites d\u2019\u00e9tude men\u00e9es en Pologne, en Norv\u00e8ge, au Portugal, en France et \u00e0 Chypre.<\/p>\n<p>Des repr\u00e9sentants d\u2019autorit\u00e9s publiques charg\u00e9es de la fixation des prix et du remboursement des produits pharmaceutiques y ont expos\u00e9 leurs pratiques, leurs constats et les implications pour la mise en \u0153uvre des politiques en mati\u00e8re de biosimilaires. Le contenu offre ainsi des \u00e9l\u00e9ments comparatifs entre plusieurs syst\u00e8mes nationaux sur les modalit\u00e9s concr\u00e8tes de soutien \u00e0 l\u2019utilisation des biosimilaires, susceptibles d\u2019int\u00e9resser les administrations impliqu\u00e9es dans l\u2019\u00e9laboration, le suivi et l\u2019ajustement des politiques de m\u00e9dicaments.  (contenu r\u00e9sum\u00e9 en fran\u00e7ais par l&rsquo;IA) \u00a0\u200b<a href=\"https:\/\/health.ec.europa.eu\/latest-updates\/presentation-and-recording-euhpp-live-webinar-biosimilar-policies-practice-key-findings-augment-2026-10-21_en\" target=\"_blank\" class=\"feedzy-rss-link-icon\">Lire la Suite<\/a><\/p>","protected":false},"excerpt":{"rendered":"<p>Un webinaire consacr\u00e9 aux politiques relatives aux biosimilaires, intitul\u00e9 \u00ab Biosimilar Policies in Practice: Key Findings from the AUGMENT Study Visits \u00bb, a \u00e9t\u00e9 mis en ligne sur la plateforme [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":17753,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","ast-disable-related-posts":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"categories":[212,7,31],"tags":[258,227,226],"class_list":["post-21792","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-gestion-des-crises","category-medicaments-et-produits-de-sante","category-politiques-europeennes-sante-social-travail","tag-hera","tag-ia","tag-sources-etrangeres"],"_links":{"self":[{"href":"https:\/\/veilles-affaires-sociales.fr\/index.php?rest_route=\/wp\/v2\/posts\/21792","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/veilles-affaires-sociales.fr\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/veilles-affaires-sociales.fr\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/veilles-affaires-sociales.fr\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/veilles-affaires-sociales.fr\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=21792"}],"version-history":[{"count":0,"href":"https:\/\/veilles-affaires-sociales.fr\/index.php?rest_route=\/wp\/v2\/posts\/21792\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/veilles-affaires-sociales.fr\/index.php?rest_route=\/wp\/v2\/media\/17753"}],"wp:attachment":[{"href":"https:\/\/veilles-affaires-sociales.fr\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=21792"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/veilles-affaires-sociales.fr\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=21792"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/veilles-affaires-sociales.fr\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=21792"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}